NL-OMON26866
Suspended
Not Applicable
Prevention of iatrogenic neurological impairment in schizophrenic disorders: the Schizophrenia Termination of Pharmacotherapy (STOP)-trial,<br> or: <br>The beneficial and negative effects of stopping with antipsychotics in schizophrenic disorders.
Divisie Hersenen0 sites20 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Schizophrenic disorders:SchizophreniaSchizophreniform disorderSchizoaffective disorder
- Sponsor
- Divisie Hersenen
- Enrollment
- 20
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Written informed consent obtained after oral and written explanation to the patient and its doctor;
Exclusion Criteria
- •1\. Judgement of the treating psychiatrist of the patient;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Schizophrenia Termination Of Pharmacotherapy: STOP-trialSchizophrenia, schizophreniform disorder, schizoaffective disorderMental and Behavioural DisordersSchizophreniaISRCTN06332944The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)20
Completed
Not Applicable
Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological HandicapsSeizuresEpilepsyNCT01459692Medical University of South Carolina40
Active, not recruiting
Phase 1
Hydrocortisone as co-treatment to prevent neuropsychiatric adverse effects of dexamethasone.europsychiatric adverse effects which can be caused by dexamethasone. For example delirium, anxiety, depression, mania and psychosis. But also cognitive impairment and sleep disturbance.Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2017-003705-17-NLMC180
Recruiting
Phase 4
Prevention of neuropsychiatric adverse effects caused by dexamethasone: insights from a placebo-controlled trial with hydrocortisone.NL-OMON54782eids Universitair Medisch Centrum180
Recruiting
Not Applicable
Prevention of cerebral lesions by improving the management of postnatal hypoglycemia and hyperinsulinismP70.0P70.1P70.4P70.8P70.9E16.1Syndrome of infant of mother with gestational diabetesSyndrome of infant of a diabetic motherOther neonatal hypoglycaemiaOther transitory disorders of carbohydrate metabolism of fetus and newbornTransitory disorder of carbohydrate metabolism of fetus and newborn, unspecifiedOther hypoglycaemiaDRKS00021474niversitätsklinikum Düsseldorf200